City
Epaper

'Vax drive for teens strengthened India's fight against Covid'

By IANS | Published: January 13, 2022 8:57 PM

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened ...

Open in App

New Delhi, Jan 13 The ongoing vaccination drive for teenagers in the 15-18 age bracket has further strengthened India's fight against the Covid-19 pandemic, N.K. Arora, Chairman of the Covid-19 Working Group of National Technical Advisory Group on Immunisation (NTAGI), told on Thursday.

"Vaccinating teenagers will give parents the confidence to send them to school and help them resume normal activities while maintaining Covid appropriate behaviour," Arora said.

Since the beginning of the vaccination drive for the 15 to 18 age group on January 3, over three crore teens have been vaccinated with the first dose so far. As per an estimation, there are around 7.50 crore teens in this age bracket in India to whom vaccine shots will be administered.

Talking about Ahmedabad-based Zydus Cadilla's ZyCovD vaccine, the world's first plasmid-DNA vaccine approved for those above 12 years, Arora said, "Since it is the first DNA vaccine, the government wants to be doubly sure of its safety before providing it to children. So, its first one crore doses will be given to adults."

"The vaccine was found to be absolutely safe and highly efficacious during the trials. We are sure that it will soon be available for children as well," he said.

"Data shows that children are as susceptible to catching the infection as adults are. The vaccine protects against severe disease. The older teenagers are quite socially active and so they are at a higher risk of catching the virus as compared to younger kids.

"

On vaccine's side-effects among teens, Manju Puri, consultant gynaecologist at Lady Hardinge Medical College, said that it is a time-tested technology which is both safe and efficacious.

No major side-effects have been reported yet, she said, adding that children, like adults, may experience mild side-effects such as pain at the vaccine site, fatigue, or mild fever for a few days.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhiindiaCovid-19 working group of national technical advisory group on immunisationNtagiManju puri
Open in App

Related Stories

BusinessIndia Witnessed a 59% Surge in Ghost Shopping Malls in 2023: 16 Retail Centers Shut Across Top Cities

NationalIndia Weather Update: IMD Warns of Heatwave Across Multiple Regions on May 6

InternationalIndian-Origin Astronaut Sunita Williams to Fly to Space Again on First Crewed Mission of Boeing’s Starliner

InternationalChina's Gold Rush: Surging Demand Lifts Prices to Record Highs

InternationalJaishankar Rejects US President Biden’s Remarks, Says, “India Not Xenophobic, but Very Open and Welcoming”

Health Realted Stories

HealthDo you know intermittent fasting protects against liver inflammation, liver cancer? Study finds

HealthPatanjali case: SC expresses displeasure over misleading advertisements continuing after product licences suspended

HealthWest Nile fever alert in three Kerala districts, 10 cases reported

HealthLack of education, misconceptions on asthma hindering treatment: Doctors

HealthElderly woman weighing 102 kgs undergoes bilateral knee replacement in Noida